NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Marker Therapeutics Inc (NASDAQ: MRKR)

 
MRKR Technical Analysis
5
As on 28th Sep 2022 MRKR SHARE Price closed @ 0.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.70 & Strong Sell for SHORT-TERM with Stoploss of 2.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MRKRSHARE Price

Open 0.34 Change Price %
High 0.35 1 Day 0.02 6.06
Low 0.34 1 Week -0.11 -23.91
Close 0.35 1 Month -0.05 -12.50
Volume 77554 1 Year -1.77 -83.49
52 Week High 3.56 | 52 Week Low 0.26
 
NASDAQ USA Most Active Stocks
AAPL 149.84 -0.62%
AVCT 0.28 -9.68%
BTRS 9.28 58.09%
AMD 68.36 3.11%
ABOS 9.58 115.77%
AMZN 118.01 2.48%
TSLA 287.81 4.28%
NVDA 127.36 4.15%
INTC 27.13 0.59%
AAL 12.75 7.50%
 
NASDAQ USA Top Gainers Stocks
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
MSACW 0.13 225.00%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
ABOS 9.58 115.77%
TRONW 0.04 100.00%
GMVDW 0.12 100.00%
CONXW 0.06 100.00%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
ZWRKW 0.03 -85.00%
FTAAW 0.02 -77.78%
SHACW 0.01 -66.67%
PHAS 0.26 -66.67%
FTVIW 0.01 -66.67%
MILEW 0.06 -53.85%
VENAW 0.01 -50.00%
SRSAW 0.03 -50.00%
NBEV 0.01 -50.00%
 
 
MRKR
Daily Charts
MRKR
Intraday Charts
Whats New @
Bazaartrend
MRKR
Free Analysis
 
MRKR Important Levels Intraday
RESISTANCE0.37
RESISTANCE0.36
RESISTANCE0.36
RESISTANCE0.36
SUPPORT0.34
SUPPORT0.34
SUPPORT0.34
SUPPORT0.33
 
MRKR Forecast October 2022
4th UP Forecast2.47
3rd UP Forecast1.79
2nd UP Forecast1.37
1st UP Forecast0.95
1st DOWN Forecast-0.25
2nd DOWN Forecast-0.67
3rd DOWN Forecast-1.09
4th DOWN Forecast-1.77
 
MRKR Weekly Forecast
4th UP Forecast2.10
3rd UP Forecast1.54
2nd UP Forecast1.19
1st UP Forecast0.85
1st DOWN Forecast-0.15
2nd DOWN Forecast-0.49
3rd DOWN Forecast-0.84
4th DOWN Forecast-1.40
 
MRKR Forecast2022
4th UP Forecast6.9
3rd UP Forecast4.8
2nd UP Forecast3.5
1st UP Forecast2.2
1st DOWN Forecast-1.5
2nd DOWN Forecast-2.8
3rd DOWN Forecast-4.1
4th DOWN Forecast-6.2
 
 
MRKR Other Details
Segment EQ
Market Capital 122956480.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MRKR Address
MRKR
 
MRKR Latest News
 
Your Comments and Response on Marker Therapeutics Inc
 
MRKR Business Profile
Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA-specific T cell technology is based on the expansion of non-engineered tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, multiple myeloma, and various solid tumors; and allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia. It is also developing TPIV100/110, which is in Phase II clinical trial for the treatment of breast cancer; and TPIV200 that is in Phase II clinical trial for the treatment of breast and ovarian cancers. Marker Therapeutics, Inc. is headquartered in Houston, Texas. Address: Phoenix Tower, Houston, TX, United States, 77027
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service